Surgery Partners (SGRY) reported Q3 adjusted net income Tuesday of $0.19 per diluted share, unchanged from a year earlier.
Analysts polled by Capital IQ expected $0.26.
Revenue for the quarter ended Sept. 30 was $770.4 million, up from $674.1 million a year earlier.
Analysts surveyed by Capital IQ expected $769.8 million.
For 2024, the healthcare services company said it continues to expect revenue of greater than $3.08 billion. Analysts polled by Capital IQ expect $3.09 billion.
Shares of Surgery Partners fell more than 12% in recent Tuesday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.